So we're three and a half years in here at Burke,” Brian Epley said. “We haven't really programmatically started or done a lot.” ...

If the attention generated by BioSpace’s coverage of this landmark approval is any indication, Americans are hungry for ...

The money will pay for efforts to prevent and treat opioid addiction, or fund services that help people in recovery.

The recent settlement that would see Purdue Pharma and its owners, the Sackler family, pay $7.4 billion to resolve lawsuits filed by state and local governments across the country is ...

Last week’s settlement that would see Purdue Pharma and its owners, the Sackler family, pay $7.4 billion to resolve lawsuits filed by state and local governments across the country is ...

Last week’s settlement that would see Purdue Pharma and its owners, the Sackler family, pay $7.4 billion to resolve lawsuits filed by state and local governments across the country is ...

Last week’s settlement that would see Purdue Pharma and its owners, the Sackler family, pay $7.4 billion to resolve lawsuits ...

Members of the family who own OxyContin maker Purdue Pharma, and the company itself, agreed to pay up to $7.4 billion in a new settlement to lawsuits over the toll ...

The greenlight for Journavx (suzetrigine), which comes on the heels of a $7.4 billion opioid settlement, could spark momentum ...

Massachusetts and other states have reached a tentative $7.4 billion settlement with the Sackler family and Purdue Pharma ...